<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Iran Medical Council</PublisherName>
				<JournalTitle>Journal of Iranian Medical Council</JournalTitle>
				<Issn>2645-338X</Issn>
				<Volume>9</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2026</Year>
					<Month>08</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Changes in Lactobacillus and Bifidobacterium Load in a Population of Iranian People with Papillary Thyroid Cancer: The Effect of Radioactive Iodine therapy</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>884</FirstPage>
			<LastPage>890</LastPage>
			<ELocationID EIdType="pii">251594</ELocationID>
			
<ELocationID EIdType="doi">http://dx.doi.org/10.18502/jimc.v9i4.22456</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Sakineh</FirstName>
					<LastName>Moghadam Shiri</LastName>
<Affiliation>Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Science, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-4460-977X</Identifier>

</Author>
<Author>
					<FirstName>Nahid</FirstName>
					<LastName>Hashemi-Madani</LastName>
<Affiliation>Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Science, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-6134-9906</Identifier>

</Author>
<Author>
					<FirstName>Sara</FirstName>
					<LastName>Cheraghi</LastName>
<Affiliation>Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Science, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-2490-2757</Identifier>

</Author>
<Author>
					<FirstName>Babak</FirstName>
					<LastName>Fallahi</LastName>
<Affiliation>Research Center for Nuclear Medicine, Dr Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-0576-1672</Identifier>

</Author>
<Author>
					<FirstName>Sara</FirstName>
					<LastName>Minaeian</LastName>
<Affiliation>Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-8787-5971</Identifier>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Honardoost</LastName>
<Affiliation>Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Science, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-1285-8456</Identifier>

</Author>
<Author>
					<FirstName>Fereshteh</FirstName>
					<LastName>Shahrabi</LastName>
<Affiliation>Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad E.</FirstName>
					<LastName>Khamseh</LastName>
<Affiliation>Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Science, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-4313-8440</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>05</Month>
					<Day>24</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background:&lt;/strong&gt; To investigate the changes in Lactobacillus and Bifidobacterium load in a population of Iranian people with Papillary Thyroid Carcinoma (PTC) before and following Radioactive Iodine (RAI) therapy.&lt;br&gt;&lt;strong&gt;Methods:&lt;/strong&gt; This longitudinal cohort study included 28 healthy individuals and 30 PTC patients referred for RAI therapy. A total of 90 stool samples from the same 30 patients with PTC were collected one day before RAI therapy, two weeks and two months following RAI therapy. As a control group, 28 stool samples were collected from 28 healthy age-sex matched individuals. Stool microbiotas were detected using 16S rRNA gene sequencing.&lt;br&gt;&lt;strong&gt;Results:&lt;/strong&gt; Lactobacillus load was significantly lower in patients with PTC compared to the healthy individuals before (2.56 vs. 4.47 copies/gr stool, p=0.01) and two weeks after RAI therapy (3.51 vs. 4.47 copies/gr stool, p=0.02). Two months after RAI therapy, there was no significant difference in the load of Lactobacillus between the two groups (5.21 vs. 4.47 copies/gr stool, p=0.69). Moreover, the load of Lactobacillus increased significantly from 2.42 copies/gr stool before RAI therapy to 3.80 copies/gr stool at two weeks, and 5.27 copies/gr stool after two months of RAI therapy (p=0.01). On the other hand, there was no difference in the abundance of Bifidobacterium between the PTC and healthy individuals at different time points. &lt;br&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; This study indicated the difference in the load of Lactobacillus in PTC patients compared to healthy individuals. Moreover, it highlighted a significant increase in the load of Lactobacillus in PTC patients following RAI therapy. These results highlight the potential for microbiota modulations as an adjuvant therapy in PTC management</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Gut microbiota</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Radioactive Iodine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">thyroid carcinoma</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.jimc.ir/article_251594_9e87c7685d8d56660d7f2be9c10bdd52.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
